6126 SARS-CoV-2 S1 IgM
The AESKULISA SARS-CoV-2 S1 IgM test is a qualitative and quantitative immunoassays for the demonstration of human IgM antibodies in serum or plasma directed against the S1 domain of the spike protein of SARS-CoV-2. The AESKULISA SARS-CoV-2 S1 IgM test assists in the detection of acute infections.
Recombinant S1 domain of the spike protein of SARS-CoV-2
Published in Infectious Serology ELISA Test Kits